Detalhe da pesquisa
1.
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
J Clin Oncol
; 39(25): 2803-2815, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077237
2.
Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
Ann Surg
; 249(4): 588-95, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19300231
3.
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370).
J Thorac Oncol
; 13(5): 682-688, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29518553
4.
A novel 5' ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome.
Haematologica
; 90(11): 1463-70, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16266892
5.
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia.
Leuk Lymphoma
; 49(1): 49-56, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18203011
6.
Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Eur J Haematol
; 77(1): 57-60, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16827884